The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The future is now: Implementation of standard of care, preemptive pharmacogenomic testing in patients with gastrointestinal cancers.
 
Emily C Hearst
No Relationships to Disclose
 
James L Martin
No Relationships to Disclose
 
Kristy R Crooks
No Relationships to Disclose
 
Casey S Greene
No Relationships to Disclose
 
Kaitlyn W Hess
No Relationships to Disclose
 
Natalie Johnson
No Relationships to Disclose
 
David P Kao
Stock and Other Ownership Interests - Codex Health, Inc
 
Nicholas Rafaels
No Relationships to Disclose
 
Katelyn Carson
No Relationships to Disclose
 
Cheryl L Meguid
No Relationships to Disclose
 
Kate Taucher
Employment - G1 Therapeutics
Leadership - APSHO
Consulting or Advisory Role - Advarra; Amneal Pharmaceuticals; Amneal Pharmaceuticals; G1 Therapeutics; Genmab; Sandoz
Speakers' Bureau - Amgen; Daiichi Sankyo/ AstraZeneca; Genentech; Ipsen; Tesaro
 
S. Lindsey Davis
Stock and Other Ownership Interests - Johnson & Johnson/MedTech
Speakers' Bureau - Allergan (I)
Research Funding - Boston Scientific (I); Bristol-Myers Squibb (Inst); EMD Serono (Inst); I-Mab (Inst); Merck (Inst); ORIC Pharmaceuticals (Inst); Symphogen (Inst); TriSalus Life Sciences (Inst); Tvardi Therapeutics (Inst)
 
Christopher Hanyoung Lieu
Consulting or Advisory Role - Amgen (Inst)
Research Funding - Genentech (Inst)
 
Christina L Aquilante
No Relationships to Disclose